Skip to main content

Fyarro 100 mg lyophilized powder for injectable suspension Images

Generic Name: sirolimus protein-bound

This medication has been identified as Fyarro 100 mg lyophilized powder for injectable suspension and is used for Malignant Perivascular Epithelioid Cell Tumor. It belongs to the drug class mTOR inhibitors and is not a controlled substance.

Images of medication

Fyarro 100 mg lyophilized powder for injectable suspension medicine

Fyarro

Generic Name
sirolimus protein-bound
Strength
100 mg lyophilized powder for injectable suspension
Availability
Prescription only
Drug Class
MTOR inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aadi Bioscience
National Drug Code (NDC)
80803-0153

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.